(Natural News) The Food and Drug Administration (FDA) recently approved a new Alzheimer’s drug even though their expert review panel rejected the fraudulent end points that were used to promote the drug’s “efficacy!” Even though the three-member panel voted unanimously against the drug, the agency overruled their expert scientific analysis and approved the new drug anyway, opting to rely on a separate measure promoted by the drug company itself. In protest, the three FDA advisors resigned from their positions, leaving bare the FDA’s compromised state and scientific fraud.
The FDA no longer functions as an effective drug regulator, nor do they properly scrutinize medical fraud. With thousands of people dying after covid vaccines, it has become glaringly obvious that a protective and law-abiding FDA does NOT exist any longer. The FDA won’t revoke the emergency use authorization for these bioweapon delivery systems, and are therefore complicit in crimes against humanity.
FDA sets “dangerous precedent” disregarding their own scientific panel
One of the men who opposed the new drug was Dr. Aaron Kesselheim, director of Brigham and Women’s Hospital Program on Regulation, Therapeutics and Law. He said the approval of the drug Adulhelm sets “a dangerous precedent” on the type of evidence an Alzheimer’s therapy would need in order to gain FDA approval. He warned that the FDA abandoned the science and allowed the drug company to “turn around and at the last minute seek [accelerated approval] when their primary clinical endpoints in their trials don’t reach the level needed for [traditional] FDA approval.”
Author: Lance D Johnson
Lance D. Johnson is a freelance investigative journalist focusing primarily on health related topics. His articles have been published by many journals, including Natural News, Nature, The Modesto Bee, Merced Sun-Star, People’s Taliba, Eastern Arizona Courier, Australian National Review, Citizens Journal and more.
